Associate Director, Biostatistics
Pliant Therapeutics is a public, clinical stage biopharmaceutical company focused on the discovery and development of novel therapies for fibrotic diseases. Founded by Third Rock Ventures with world-renowned academic thought leaders, Pliant is raising the bar to meet the unmet medical needs of physicians, patients and families impacted by fibrotic disease. The Company’s focus is on mechanism-based intervention in the fibrotic process using small molecules.
The Company’s lead product candidate, PLN-74809, is an oral, small molecule selective inhibitor of the αvβ1 and αvβ6 integrins that play a key role in multiple fibrotic pathways. PLN-74809 has received Orphan Drug Designation from the U.S. Food and Drug Administration in both idiopathic pulmonary fibrosis (IPF) and primary sclerosing cholangitis (PSC) and are currently in Phase 2a clinical trials for these indications. The company recently reported positive data from its Phase 2a trial in IPF and is currently ramping up activities in preparation for a late-stage clinical trial at worldwide sites.
Pliant has also developed PLN-1474, a small molecule, selective inhibitor of αvß1 for the treatment of nonalcoholic steatohepatitis, or NASH with liver fibrosis. Pliant is initiating a Phase 1 study for its third clinical program, PLN-101095, a small molecule, dual-selective inhibitor of αvß8 and αvß1 integrins, that is being developed for the treatment of solid tumors. The Company also has discovery and development programs in oncology and muscular dystrophies.
The Company is seeking passionate, creative, and dedicated individuals to join our team and contribute to our mission.
The Associate Director, Biostatistics is a critical member of the statistical team, who provides study level statistical support in cross-functional settings including participating in study design, sample size calculations, supervision of CRO, reviewing statistical analysis plan, TFL shells, CRF, DSMB charter, TFL outputs, abstracts, CSR, IND, ISS, ISE, managing study timelines. Some hands-on ad-hoc analyses may be required outside of the CRO provided outputs.
- Responsible for statistical input to clinical development plans, clinical study concepts and protocols, case report forms, clinical study reports, regulatory documents, scientific publications, internal and external meetings, and presentations.
- Accountable for development, implementation and execution of statistical analysis plans that support clinical development plans and clinical protocols, to ensure statistical integrity, adequacy and accuracy.
- Accountable for production of biostatistics deliverables (planned, post-hoc, and/or exploratory analyses) by providing oversight of the work performed by CROs, managing external Biostatistics and Statistical Programming consultants, as needed, or performing the work themselves, to ensure timeliness and quality of analysis data and statistical outputs.
- Contribute to developing Departmental standards (CRF design, ADaM datasets, TFL Mocks).
- Responsible for development and interpretation of topline study results in close collaboration with the clinical and cross-functional teams.
- Participate in global regulatory interactions including filings, written, oral and face to face interactions, as needed.
- Lead one or more department initiatives.
- Ensure all biostatistics activities comply with industry norms, health authority regulations, ICH/GCP guidelines and company SOPs.
To perform this job successfully, an individual must be able to perform each essential duty. The requirements listed below are representative of the knowledge, skill, abilities and prior experience required.
- PhD or MS in statistics or mathematics.
- At least 5 - 7 years of pharma / biotech industry experience. Rare disease or Oncology experience is a plus.
- Comprehensive knowledge of clinical trials methodology, and statistical software packages. Proficiency in SAS required, and knowledge of other languages (R) is a plus.
- Comprehensive knowledge of FDA/EMA/ICH guidelines for statistical and clinical data analysis, data structure, and new developments and industry standards in statistics and drug development.
- Proven experience within both early and late-stage development phases, including selection of relevant clinical study endpoints and outcome measures.
- Preferred experience managing external statistical and programming resources.
- Proven track record of innovative approaches such as adaptive clinical trial design.
- Excellent interpretation and presentation skills and ability to communicate statistical concepts and data to non-statisticians.
- Advanced knowledge of CDISC requirements for SDTM and ADaM.
- Knowledge of clinical data management systems.
- Able to collaborate effectively with internal, cross-functional, and external study teams to meet project timelines.
- Excellent organizational skills and attention to detail.
- Able to set priorities and juggle multiple projects and demands.
- Able to work independently while exercising initiative, flexibility, and sound judgment.
- Ability to operate in alignment with Pliant’s values.
- This position will require relocation to the bay area.
- We require three days per week in our South San Francisco Office.
- We will provide relocation assistance.
Pliant requires all new hires to be fully vaccinated prior to the first date of employment (subject to any legally required exemptions).
The annual base salary for this role is $170,000 - $200,000. Individual pay may vary based on additional factors, including, and without limitation job-related skills, experience, work location and relevant education or training. Pliant’s compensation package also includes benefits, equity, and annual target bonus for fulltime positions.
To understand how Pliant complies with and manages your personal information with respect to the California Consumer Privacy Act, please visit https://pliantrx.com/ccpa-applicant-and-staff-privacy-notice/.